4093-34-9Relevant articles and documents
Preparation method for pharmacopoeia impurity of amisulpride
-
Paragraph 0013; 0024-0025, (2021/06/26)
The invention reports a preparation method for a pharmacopoeia impurity of amisulpride, and particularly relates to a preparation method for the pharmacopoeia impurity D of amisulpride. The method is simple and easy to operate, mild in condition, high in yield, low in energy consumption and pollution and suitable for laboratory-level standard substance preparation.
QUINAZOLINE-BASED KINASE INHIBITORS
-
Page/Page column 126, (2016/04/26)
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
ANTIVIRAL COMPOUNDS
-
Paragraph 0543, (2015/03/13)
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).